The Impacts of Surgical Visibility Through Deep Neuromuscular Blockade on Intraocular Pressure in Patients Undergoing Robot-Assisted Laparoscopic Radical Prostatectomy

June 21, 2015 updated by: Yonsei University
Intraocular pressure is significantly increase during robot-assisted laparoscopic radical prostatectomy which is performed in a steep trendelenburg position at prolonged times of pneumoperitoneum. Therefore investigators decided to evaluate the impacts of surgical visibility through deep neuromuscular blockade on intraocular pressure in patients undergoing Robot-Assisted Laparoscopic Radical Prostatectomy.

Study Overview

Study Type

Interventional

Enrollment (Actual)

67

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Seoul, Korea, Republic of, 120-752
        • Department of Anesthesiology and Pain Medicine, Yonsei University College of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

50 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  1. ASA class I-II
  2. obtaining written informed consent from the parents
  3. aged over 50 years who were undergoing robot- assisted laparoscopic prostatectomy

Exclusion Criteria:

  1. eye surgery previously
  2. unstable angina or congestive heart failure
  3. concomitant eye disease (glaucoma, diabetic retinopathy, cataract, retinal detachment)
  4. high intraocular pressure over 30mmHg after screening test.
  5. uncontrolled hypertension (diastolic bp>110mmHg)
  6. coagulopathy
  7. asthma
  8. hepatic failure
  9. renal failure(creatinine clearance < 30 ml/min)
  10. drug hyperactivity
  11. neurological or psychiatric illnesses
  12. mental retardation
  13. patients who can't read the consent form due to illiterate or foreigner
  14. previous malignant hyperthermia Hx
  15. drug medication which interact with muscle relaxant (anti-convulsant, certain antibiotics, magnesium etc)
  16. BMI > 30kg/m2

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Deep neuromuscular blockade
deep neuromuscular blockade using rocuronium and reverse with sugammadex
Active Comparator: moderate neuromuscular blockade
moderate neuromuscular blockade using atracurium and reverse with neostigmine

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Maximum Intraocular Pressure During RALRP Under Deep Neuromuscular Blockade
Time Frame: Maximum intraocular pressure was measured at 60 minutes after CO2 pneumoperitoneum in the ST position
maximum intraocular pressure during RALRP under deep neuromuscular blockade after being positioned in the steep Trendelenburg position with CO2 pneumoperitoneum under deep neuromuscular blockade
Maximum intraocular pressure was measured at 60 minutes after CO2 pneumoperitoneum in the ST position

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Overall Surgical Condition
Time Frame: At the end of the Steep trendelenburg position, an average of 1 hour
overall surgical conditions using the 5-point rating scale as previously described: Grade 5 (optimal), optimal surgical conditions; grade 4 (good), nonoptimal conditions, but an intervention is not required; grade 3 (acceptable), wide surgical view, but an intervention can improve surgical conditions, grade 2 (poor), inadequate conditions, there is a visible view, but an intervention is necessary to ensure acceptable surgical conditions; grade 1 (extremely poor), inability to perform surgery; therefore, intervention is necessary.
At the end of the Steep trendelenburg position, an average of 1 hour

Other Outcome Measures

Outcome Measure
Time Frame
Post-operative Nausea
Time Frame: During 24hours after operation
During 24hours after operation
Incidence of Residual Neuromuscular Blockade
Time Frame: During 24hours after operation
During 24hours after operation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

May 1, 2014

Primary Completion (Actual)

December 1, 2014

Study Completion (Actual)

December 1, 2014

Study Registration Dates

First Submitted

March 30, 2014

First Submitted That Met QC Criteria

April 8, 2014

First Posted (Estimate)

April 9, 2014

Study Record Updates

Last Update Posted (Estimate)

June 24, 2015

Last Update Submitted That Met QC Criteria

June 21, 2015

Last Verified

June 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Robot-Assisted Laparoscopic Radical Prostatectomy

Clinical Trials on Rocuronium

3
Subscribe